MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB
Publication
, Conference
Peters, KB; Affronti, ML; Threatt, S; Healy, P; Herndon, JE; Lipp, ES; Panta, S; Randazzo, D; Friedman, HS; Desjardins, A
Published in: NEURO-ONCOLOGY
November 1, 2017
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2017
Volume
19
Start / End Page
206 / 206
Location
San Francisco, CA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Affronti, M. L., Threatt, S., Healy, P., Herndon, J. E., Lipp, E. S., … Desjardins, A. (2017). MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. In NEURO-ONCOLOGY (Vol. 19, pp. 206–206). San Francisco, CA: OXFORD UNIV PRESS INC.
Peters, Katherine B., Mary Lou Affronti, Stevie Threatt, Patrick Healy, James E. Herndon, Eric S. Lipp, Sujata Panta, Dina Randazzo, Henry S. Friedman, and Annick Desjardins. “MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB.” In NEURO-ONCOLOGY, 19:206–206. OXFORD UNIV PRESS INC, 2017.
Peters KB, Affronti ML, Threatt S, Healy P, Herndon JE, Lipp ES, et al. MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 206–206.
Peters, Katherine B., et al. “MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB.” NEURO-ONCOLOGY, vol. 19, OXFORD UNIV PRESS INC, 2017, pp. 206–206.
Peters KB, Affronti ML, Threatt S, Healy P, Herndon JE, Lipp ES, Panta S, Randazzo D, Friedman HS, Desjardins A. MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 206–206.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2017
Volume
19
Start / End Page
206 / 206
Location
San Francisco, CA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences